Abstract |
Fifty patients with symptomatic type I atrial flutter in whom termination of the arrhythmia with transesophageal stimulation was unsuccessful were randomized to undergo a repeat procedure after intravenous propafenone (n = 25) or placebo (n = 25). Immediate sinus rhythm recovery rate was 36% in the propafenone group and 4% in the placebo group (p = 0.005), indicating that intravenous propafenone increases the rate of successful transesophageal stimulation and can be used when a first attempt at conversion is ineffective.
|
Authors | D D'Este, E Bertaglia, R Mantovan, A Zanocco, M Franceschi, P Pascotto |
Journal | The American journal of cardiology
(Am J Cardiol)
Vol. 79
Issue 4
Pg. 500-2
(Feb 15 1997)
ISSN: 0002-9149 [Print] United States |
PMID | 9052359
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Arrhythmia Agents
- Propafenone
|
Topics |
- Aged
- Anti-Arrhythmia Agents
(therapeutic use)
- Atrial Flutter
(therapy)
- Electric Countershock
(methods)
- Heart Rate
- Humans
- Middle Aged
- Propafenone
(therapeutic use)
- Prospective Studies
- Treatment Outcome
|